E-cigarettes: Safe to recommend to patients?

Cleveland Clinic Journal of Medicine

Volumn 82, Issue 8, 2015, Pages 521-526

  Jerry, Jason M ^a   Collins, Gregory B ^b   Streem, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRONIC CIGARETTE; HUMAN; SAFETY;

ELECTRONIC CIGARETTES; HUMANS; SAFETY;

EID: 84955500097     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.82a.14054     Document Type: Review

References (44)

1. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta, GA; 2014.
2. Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther 2005; 78:689-696.
3. Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 1999; 318:285-288.
4. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta, GA; 2010.
5. US Food and Drug Administration (FDA). Drugs@FDA. FDA approved drug products. www.accessdata.fda.gov/scripts/cder/drugsatfda/. Accessed May 31, 2015.
6. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 11:CD000146.
7. US Department of Health and Human Services, Food and Drug Administration. Now available without a prescription. www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143547.htm. Accessed May 31, 2015.
8. McQueen A, Tower S, Sumner W. Interviews with "vapers": implications for future research with electronic cigarettes. Nicotine Tob Res 2011; 13:860-867.
9. Kamerow D. Big Tobacco lights up e-cigarettes. BMJ 2013; 346:f3418.
10. Robehmed N. E-cigarette sales surpass $1 billion as big tobacco moves in. Forbes. www.forbes.com/sites/natalierobehmed/2013/09/17/e-cigarette-sales-surpass-1-billion-as-big-tobacco-moves-in/. Accessed May 31, 2015.
11. US Department of Health and Human Services, Food and Drug Administration. Deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act, as amended by the family smoking prevention and tobacco control act; regulations on the sale and distribution of tobacco products and required warning statements for tobacco products; proposed rule. Federal Register 2014; 79:23141-23207.
12. Petros WP, Younis IR, Ford JN, Weed SA. Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy 2012; 32:920-931.
13. Lane D, Gray EA, Mathur RS, Mathur SP. Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am J Reprod Immunol 2005; 53:153-158.
14. Ginzel KH, Maritz GS, Marks DF, et al. Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol 2007; 12:215-224.
15. NeunteuflT, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39:251-256.
16. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control 2014; 23:77-78.
17. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011; 49:910-941.
18. Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012; 50:911-1164.
19. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol (Phila) 2013; 51:949-1229.
20. Gahring LC, Rogers SW. Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J 2006; 7:E885-E894.
21. Pellegrino RM, Tinghino B, Mangiaracina G, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 2012; 24:279-288.
22. Westenberger BJ. Evaluation of e-cigarettes. St. Louis, MO: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis, 2009. www.fda.gov/downloads/drugs/scienceresearch/ucm173250.pdf. Accessed May 31, 2015.
23. Robertson OH, Loosli CG, Puck TT, et al. Tests for the chronic toxicity of propylene glycol and triethylene glycol on monkeys and rats by vapor inhalation and oral administration. J Pharmacol Exp Ther 1947; 91:52-76.
24. Riker CA, Lee K, Darville A, Hahn EJ. E-cigarettes: promise or peril? Nurs Clin North Am 2012; 47:159-171.
25. Dow Chemical Company. A Guide to Glycols. http://msdssearch.dow. com/PublishedLiteratureDOWCOM/dh_091b/0901b8038091b508.pdf?filepath=propyleneglycol/pdfs/noreg/117-01682.pdf&fromPage=GetDoc. Accessed May 31, 2015.
26. Varughese S, Teschke K, Brauer M, Chow Y, van Netten C, Kennedy SM. Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am J Ind Med 2005; 47:411-418.
27. Arif AA, Whitehead LW, Delclos GL, Tortolero SR, Lee ES. Prevalence and risk factors of work related asthma by industry among United States workers: data from the third national health and nutrition examination survey (1988-94). Occup Environ Med 2002; 59:505-511.
28. Wieslander G, Norbäck D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 2001; 58:649-655.
29. Moline JM, Golden AL, Highland JH, Wilmarth KR, Kao AS. Health effects evaluation of theatrical smoke, haze and pyrotechnics. Prepared for Actor's Equity Pension and Health Trust Funds. www.equityleague.org/PDF/smokehaze/execsummary.pdf. Accessed May 31, 2015.
30. Funk JO, Maibach HI. Propylene glycol dermatitis: re-evaluation of an old problem. Contact Dermatitis 1994; 31:236-241.
31. Connolly M, Buckley DA. Contact dermatitis from propylene glycol in ECG electrodes, complicated by medicament allergy. Contact Dermatitis 2004; 50:42.
32. Skaare A, Kjaerheim V, Barkvoll P, Rølla G. Skin reactions and irritation potential of four commercial toothpastes. Acta Odontol Scand 1997; 55:133-136.
33. Peleg O, Bar-Oz B, Arad I. Coma in a premature infant associated with the transdermal absorption of propylene glycol. Acta Paediatr 1998; 87:1195-1196.
34. Fisher AA. Systemic contact dermatitis caused by ingestion of certain foods in propylene glycol-sensitive patients. Am J Contact Dermat 1996; 7:259.
35. Demey HE, Daelemans RA, Verpooten GA, et al. Propylene glycolinduced side effects during intravenous nitroglycerin therapy. Intensive Care Med 1988; 14:221-226.
36. Demey H, Daelemans R, De Broe ME, Bossaert L. Propyleneglycol intoxication due to intravenous nitroglycerin. Lancet 1984; 1:1360.
37. Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 2014;14:18.
38. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23:133-139.
39. Stepanov I, Carmella SG, Han S, et al. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob Res 2009; 11:99-105.
40. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 2011; 32:16-31.
41. Coulson H. Analysis of components from Gamucci electronic cigarette cartridges, tobacco flavor regular smoking liquid 2009. Report number: E98D. LPD Lab Service. March 3, 2009. http://truthaboutecigs.com/science/7.pdf. Accessed May 31, 2015.
42. Laugesen M. Safety report on the Ruyan e-cigarette cartridge and inhaled aerosol. Christchurch, New Zealand: Health New Zealand Ltd., October 30, 2008. www.healthnz.co.nz/RuyanCartridgeReport30-Oct-08.pdf. Accessed May 31, 2015.
43. Uchiyama S, Inaba Y, Kunugita N. Determination of acrolein and other carbonyls in cigarette smoke using coupled silica cartridges impregnated with hydroquinone and 2, 4-dinitrophenylhydrazine. J Chromatogr A 2010; 1217:4383-4388.
44. Bhatnagar A, Whitsel LP, Ribisl KM, et al. American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Electronic cigarettes: a policy statement from the American Heart Association. Circulation 2014; 130:1418-1436.